bioMérieux S.A. (VIE:BIM)

Market Cap	11.18B -17.2%
Revenue (ttm)	4.07B +2.3%
Net Income	397.50M -8.0%
EPS	3.34 -8.2%
Shares Out	n/a
PE Ratio	28.13
Forward PE	19.89
Dividend	0.90 (0.94%)
Ex-Dividend Date	Jun 9, 2025

Volume	n/a
Average Volume	13
Open	95.10
Previous Close	94.70
Day's Range	95.10 - 95.10
52-Week Range	92.10 - 128.20
Beta	n/a
RSI	43.86
Earnings Date	Feb 27, 2026

About bioMérieux

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system (PCR); BIOFIRE SPOTFIRE, a lowplex PCR point-of...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1963
• Employees: 14,451
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: BIM

Financial Performance

In 2025, bioMérieux's revenue was 4.07 billion, an increase of 2.26% compared to the previous year's 3.98 billion. Earnings were 397.50 million, a decrease of -8.03%.